Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01260506
Title Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Vascular Biogenics Ltd. operating as VBL Therapeutics
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Boston Massachusetts United States Details
Duke University Medical Center Durham North Carolina United States Details
Uthsc- Ctrc San Antonio Texas United States Details
Tel Aviv Sourasky Medical Center Tel Aviv 64239 Israel Details
*Shaded cells indicate that there was no data available from for the field